| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191364 | Annals of Allergy, Asthma & Immunology | 2014 | 6 Pages |
Abstract
This review suggests that heliox benefits in airflow limitation and hospital admissions could be considered clinically significant. Data support the use of heliox as a nebulizing β2-agonist driving gas in the routine care of patients with acute asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Gustavo J. MD, Jose A. MD, PhD,